Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-21 as an early predictor of interferon-alpha response in chronic hepatitis B
ChiCTR-TRC-12002888Phase 4Completed
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Jul 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon alfa in Chronic Hepatitis B (CHB), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoints: liver function, HBV DNA quantitation and 5 more. Started Jul 2012; status: completed.
02
Drugs
interferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-12002888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002888.